Artivion, Inc. (AORT) Stock Analysis

Artivion, Inc. (AORT) Stock Analysis — AI Research | MarketCI

AORT

Market Closed

Artivion, Inc.

NYSEHealthcare Medical - Devices

1.80K employees

CEO: James Patrick Mackin

Founded: 1993

$25.28

+$0.00(+NaN%)

Market Cap

1.23B

Beta

1.25

52W Range

N/A

Dividend Yield

0.47%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

AORT Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for AORT built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Strong Sell

Pass %

42.86%

Score

3/7

Fair Value Estimate

Cash flow analysis • Multiple methods

-$0.45

AI Price Target

Machine learning • Price prediction

$18.76

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$2.49

Financial Health

Bankruptcy risk assessment

2.24

Quality Score

Financial strength rating

6.00

AI Investment Grade

Deep analysis of filings & news

72.00

Key Investment Highlights

Important factors affecting AORT investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

48.65% Poor

Conditions Met

18.00/37.00

Due Diligence Score

48.65%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Pass
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions